Cargando…
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
Despite the availability of various treatment options, colorectal cancer (CRC) remains a significant contributor to cancer-related mortality. Current standard-of-care interventions, including surgery, chemotherapy, and targeted agents like immune checkpoint blockade and anti-angiogenic therapies, ha...
Autores principales: | McCormick, Amanda L., Anderson, Trevor S., Daugherity, Elizabeth A., Okpalanwaka, Izuchukwu F., Smith, Savanna L., Appiah, Duke, Lowe, Devin B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578441/ https://www.ncbi.nlm.nih.gov/pubmed/37849752 http://dx.doi.org/10.3389/fimmu.2023.1241949 |
Ejemplares similares
-
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
por: Anderson, Trevor S., et al.
Publicado: (2023) -
DLK1 Is a Somato-Dendritic Protein Expressed in Hypothalamic Arginine-Vasopressin and Oxytocin Neurons
por: Villanueva, Carine, et al.
Publicado: (2012) -
TRIM28 Regulates Dlk1 Expression in Adipogenesis
por: Lu, Hsin-Pin, et al.
Publicado: (2020) -
Dlk1 dosage regulates hippocampal neurogenesis and cognition
por: Montalbán-Loro, Raquel, et al.
Publicado: (2021) -
Identification of genes directly responding to DLK1 signaling in Callipyge sheep
por: Yu, Hui, et al.
Publicado: (2018)